Placeholder

LabCentral Houses Scientific Visionaries
Engaged in Early-Stage Research

Abexxa Biologics, Inc.

Abexxa Biologics, Inc. is a research stage bio-pharmaceutical company focused on discovering and developing breakthrough antibody-based drugs to its proprietary class of targets designed to revolutionize cancer treatments by providing highly effective targeted therapies. The foundation of the company's technology is based on more than 25 years' experience in novel immunotherapy research.

  • Jon Weidanz, PhD Co-Founder and Chief Scientific Officer
  • Debra Weidanz, MS Co-Founder and Chief Executive Officer